Precision Capital
Advancing Precision Health

Improving Healthcare Through Disruptive Innovation

Medical Excellence Capital (MEC) is an early stage life sciences fund that combines a unique global network of leading physician scientists with a team of experienced investors, company builders, and operators.

Focusing on the Future of Precision Health

At MEC, we believe the post Covid-19 era will lead to a golden age in innovation within the life sciences space.

MEC invests in company creation, seed and Series A opportunities where technology and novel approaches are transformational including, but not limited to:

Gene Therapy
Cell Therapy
Synthetic Biology
Regenerative Medicine
AI-Enabled Drug Discovery & Development

Tapping into a Global Network of Opportunity

MEC leverages Medical Excellence Group’s (MedEx) proprietary physician and academic medical center platform to curate a unique deal flow of emerging, breakthrough technologies thoroughly vetted by our own team of industry experts.

1100+

Top Physicians
and Scientists

30+

Major Academic
Medical Centers

300+

Family
Offices

Leveraging Unparalleled Industry Expertise

We created the MEC Council, a carefully-curated subset of our 1,100+ physician/scientist panel to create a unique competitive edge. The Council enables us to get smart very quickly on a complex business opportunity theme, evaluate an investment hypothesis, or to accelerate the development of an existing MEC portfolio company.

MEC Council members include acclaimed subject matter experts across all areas of healthcare and biotech, from drug discovery researchers to experts in clinical development and regulatory requirements.

Purpose Built Team

MEC is comprised of seasoned investors and health venture operators, each with a track record of success across multiple sectors in healthcare investment and operating environments.

John Prufeta, MBA

Founder, CEO & General Partner

Eric Heil, MBA

Managing Partner

Kim Kamdar, PhD

Managing Partner

Brian Halak, PhD

Managing Partner

Joni Mancini, CPA

Managing Partner & COO/CFO

Olga Prufeta

MEC LP Liaison;
Medical Excellence Group

John Hornbostel, Esq.

Counsel

Kevin Emesiani, PharmD, MBA

Associate

Engaging with World-Class Scientific Advisors

Acclaimed innovators themselves in the fields of regenerative medicine, gene therapy, and mitochondrial medicine, the MEC scientific advisory board brings critical perspective to evaluating new opportunities and providing added value to portfolio companies.